Novel selective ACKR3 modulators and uses thereof

Andy Chevigne (Inventor), Max Meyrath (Inventor), Martyna Szpakowska (Inventor)

Research output: Patent

Abstract

The application discloses selective ACKR3 modulating peptides comprising amino acid sequence FGGX1MRRX2 (SEQ ID NO: 1), wherein X1 is F or W; X2 is K, V or F; and wherein the peptides have a length of at most 15 amino acids; fusion proteins comprising the peptides as taught herein; nucleic acids encoding the peptides as taught herein; nucleic acid expression cassettes and vectors comprising the nucleic acid as taught herein; and pharmaceutical compositions comprising the peptide as taught herein or the nucleic acid as taught herein. Further provided are the peptide as taught herein for use as a medicament; methods for in vitro or ex vivo diagnosis, prediction, prognosis and/or monitoring of a disease or condition characterized by an aberrant level of ACKR3 polypeptide using the peptide as taught herein; and in vitro methods for identifying an agent useful as a therapeutic using the peptide as taught herein.
Original languageEnglish
IPCWO 2020/225070
Publication statusPublished - 12 Nov 2020

Fingerprint

Dive into the research topics of 'Novel selective ACKR3 modulators and uses thereof'. Together they form a unique fingerprint.

Cite this